Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05746182 · ClinicalTrials.gov registry record
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
A clinical trial of Pancreatic Neuroendocrine Neoplasm, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT05746182 is a study of Pancreatic Neuroendocrine Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 300 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT05746182, a study of Pancreatic Neuroendocrine Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Hereditary Cancer Panel
Study Locations (3)
California
- University of California, Los Angeles - Los Angeles
- Univeristy of California, San Diego - San Diego
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-04-07 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05746182
The ClinicalTrials.gov registry entry for NCT05746182 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Neuroendocrine Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Hereditary Cancer Panel is the first listed.
NCT05746182 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05746182 about?
NCT05746182 is a clinical study titled "Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms". This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Tes...
What is the current status of trial NCT05746182?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-04-07. Estimated completion is 2026-12-31.
What conditions does trial NCT05746182 study?
This clinical trial studies the following conditions: Pancreatic Neuroendocrine Neoplasm.
What interventions are being tested in trial NCT05746182?
The interventions under investigation include: Hereditary Cancer Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05746182?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05746182 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neuroendocrine Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.